E
Sutro Biopharma, Inc. STRO
$0.8578 $0.01021.20% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -11.50M -75.97M -72.44M -48.79M -48.02M
Total Depreciation and Amortization 1.90M 1.90M 1.87M 1.80M 1.79M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.46M 15.33M 14.57M -10.41M 7.31M
Change in Net Operating Assets -50.58M -9.15M -15.74M -7.12M 48.37M
Cash from Operations -44.72M -67.88M -71.74M -64.52M 9.46M
Capital Expenditure -86.00K -1.17M -1.07M -828.00K -756.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 2.67M -15.08M 88.56M 148.12M -79.62M
Cash from Investing 2.58M -16.26M 87.49M 147.29M -80.38M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 0.00 0.00 0.00
Issuance of Common Stock 0.00 246.00K 0.00 1.09M 96.53M
Repurchase of Common Stock -60.00K -180.00K -24.00K -74.00K -37.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -60.00K 66.00K -24.00K 1.02M 96.49M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -42.20M -84.08M 15.73M 83.79M 25.57M